Recent News and Articles on the Keywords: mrsa + 0.21 + 153  Related to the article below (Last Update: 8/5/2008)


BBC News
Maggots could help in MRSA battle
BBC News, UK -
Scientists hope maggots can help produce an antibiotic that can tackle strains of the MRSA superbug. The researchers at Swansea University are developing ...
Maggots to fight MRSA? ITV.com
British researchers develop new drug - with maggots AFP
Maggot secretions could provide drug that can kill 12 strains of ... Daily Mail
Medical News Today (press release) - The Press Association
all 13 news articles »
First Molecular Tem-PCR Test to Identify Multiple Forms of Staph ...
MarketWatch - Aug 4, 2008
The Centers for Disease Control and Prevention (CDC) has reported that MRSA infections have doubled in the past six years. The ability to accurately ...

Washington Post
Hand Washing: Time Well Spent
Washington Post, United States -
... trillion organisms and that our hands are like swabs for the transmission of antibiotic-resistant bacteria such as MRSA, pseudomonas and C. difficile. ...
As unhygienic as a hospital! VietNamNet Bridge
all 2 news articles »
TANCS Steam Vapor Wipes Out MRSA and VRE
PR Web (press release), WA - Aug 4, 2008
Studies with MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococcus faecalis) demonstrated complete surface ...
The Germs Are Potent. But So Is a Kiss.
New York Times, United States -
Hardy organisms like MRSA evolve to withstand the drugs; then, through vectors like the unwashed hands of health care workers, they hitch a ride from ...
Infections success for East Lancs hospitals
Lancashire Telegraph, UK - Aug 3, 2008
HOSPITALS in East Lancashire have had only one case of MRSA in two months, while clostridium difficile rates have fallen by almost 70 per cent. ...
Swab tests for MRSA
Reading Evening Post, UK - Jul 30, 2008
A simple phone call from the Royal Berkshire Hospital revealed Evening Post reporter Fiona Gray tested negative for the super bug MRSA on Friday. ...
Hospitals to be refused payment if patients contract superbugs
Forester, UK - Aug 4, 2008
In 2007-08 the number of MRSA cases at the two hospitals fell to 36 from 68 the previous year. Numbers of clostridium difficile infections in patients over ...
Hospital sees drop in superbugs
East Anglian Daily Times, UK - Jul 30, 2008
According to a latest report, Ipswich Hospital has seen drops in cases of MRSA and Clostridium difficile (C-diff) within the last 12 months. ...

Grimsby Evening Telegraph
HOSPITAL VISITORS TOLD TO WASH THEIR HANDS
Grimsby Evening Telegraph, UK - Aug 1, 2008
... visiting patients are being urged to use the new hand-wash stations in the battle against infections such as potentially-fatal C-Difficile and MRSA. ...
Source: Google News

Staphylococcus aureus Bacteremia, Australia
T Australia-wide - Emerg Infect Dis, 2005 - medscape.com
... OBDs- excluding 1 day only, 0.10, 0.21, 0.22, 0.09, ... days; MSSA, methicillin-susceptible
S. aureus ; MRSA, methicillin-resistant S ... x1,000), 2,585, 561, 486, 153, 165 ...

Determinants of Glycopeptides Consumption in Hospitals -
AM Rogues, C Dumartin, A Lasheras, AG Venier, A … - Microbial Drug Resistance, 2007 - liebertonline.com
... Intensive care units 35 46.51 7.19 134 16.31 1.72 153 ... DDD per 1,000 PD: median 5.66
(range 0.21?27.2) with ... MRSA incidence per 1,000 PD and the proportion of ...

Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially … -
E Giantsou, N Liratzopoulos, E Efraimidou, M … - Intensive Care Medicine, 2005 - Springer
... Underlying malignancy 10 (7%) 7 (14%) 0.21 ... P. aeruginosa and Acinetobacter species
as well as MRSA, and the ... Am J Respir Crit Care 153:1711?1725 4. Baker AM ...

Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and … -
CD Salgado, BM Farr, DP Calfee - Clinical Infectious Diseases, 2003 - UChicago Press
... to have MRSA (RR, 0.10; 95% CI, 0.05?0.21). ... S. Community-acquired methicillin-resistant
Staphylococcus aureus (MRSA) at a ... Infect Control 1983; 4:153?7 ...

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS FREE ELECTIVE ORTHOPAEDIC SURGERY
A Datta, AC Gardner, KM Bell - Orthopaedic Proceedings, 2005 - JBJS (Br)
... Orthopaedic Proceedings Vol 87-B, Issue SUPP II, 153. ... ward free from multi resistant
staphylococcus aureus (MRSA). ... had an infection rate of 0.21% for total ...

INTRAPORTAL TRANSFUSION OF DONOR SPECIFIC LEUKOCYTES IN ADULT ABO-INCOMPATIBLE LIVING DONOR LIVER …
Y Sato, S Yamamoto, H Oya, H Nakatsuka, T … - American Journal of Transplantation, 2006 - pt.wkhealth.com
... 2.August 2006.p 153. ... case from ABO-incompatible donors (GV/RBW ratio: 0.78?}0.21)
from August ... because of the sepsis caused by preoperative MRSA pyothorax and ...

Analysis of Typing Methods for Epidemiological Surveillance of both Methicillin-Resistant and … -
NA Faria, JA Carrico, DC Oliveira, M Ramirez, H de … - Journal of Clinical Microbiology, 2008 - Am Soc Microbiol
... entire collection of 198 strains, 56 PFGE types (80% cutoff) and 153 PFGE subtypes ...
This value was lower in the MRSA data set (W = 0.21) but, interestingly ...

ACCEPTED
NA Faria, JA Carrico, DC Oliveira, M Ramirez, H de … - Journal of Clinical Microbiology - Am Soc Microbiol
... types (80% cut-off) and 153 PFGE subtypes (95% cut-off) were detected, ... 15 PFGE type.
This value is lower in the MRSA dataset (W=0.21), but interestingly ...
-

Compliance With Guidelines on Antibiotic Prophylaxis in Total Hip Replacement Surgery: Results of a … -
P Bedouch, J Labarere, E Chirpaz, B Allenet, A … - Infection Control and Hospital Epidemiology, 2004 - UChicago Press
... duration and modality of antibiotic prophylaxis, predefined risk factors for
colonization with methicillin-resistant Staphylococcus aureus (MRSA), and the ...

Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci … -
JI Blenkharn, JH Darrell - European Journal of Clinical Microbiology & Infectious …, 1989 - Springer
... 0.18g calcium chloride (dihydrate) and 0.21g magnesium ... bac- teria, including multiply
resistant strains and MRSA. ... Chemotherapy 1985, 15, Supplement A: 153-157. ...

Source: Google Scholar
 

   
   

Overview

Methicilllin-resistant Staphylococcus aureus (MRSA) infection may be one of the most frightening illnesses you've never heard of. Unlike more galvanizing diseases such as smallpox and bird flu, MRSA infection has quietly been killing and maiming hundreds of thousands of vulnerable people, including children, without grabbing a single headline.

One reason may be that staphylococcus aureus bacteria, often simply called staph, are common — they're found on the skin or in the nose of about one-third of the population. The bacteria are generally harmless unless they enter the body through a cut or other wound, and even then they often cause only minor skin problems in healthy people. But in older adults and people who are ill or have weakened immune systems, ordinary staph infections can be deadly.

Decades ago, a strain of staph emerged in hospitals that was resistant to the broad-spectrum antibiotics commonly used to treat it. Dubbed methicillin-resistant Staphylococcus aureus (MRSA), it was one of the first germs to outwit all but the most powerful drugs. Since then, MRSA infection has flourished in hospitals and care facilities worldwide, where it can cause massive infections in bones, joints, the bloodstream and surgical wounds. When not treated properly, MRSA infection is fatal.

In the 1990s, a type of MRSA began showing up in the wider community. Today, that form of staph, known as community-associated MRSA, or CA-MRSA, is responsible for most serious skin and soft tissue infections and for a lethal form of pneumonia.

Vancomycin is one of the few antibiotics still effective against hospital strains of MRSA infection, although the drug is no longer effective in every case. Several drugs continue to work against CA-MRSA, but CA-MRSA is a dangerous and rapidly evolving bacterium, and it may simply be a matter of time before it, too, becomes resistant to most antibiotics.

Signs and symptoms

Staph infections, including MRSA, generally start as small red bumps that resemble pimples, boils or spider bites. These can quickly turn into deep, painful abscesses that require surgical draining. Sometimes the bacteria remain confined to the skin. But they can also burrow deep into the body, causing potentially life-threatening infections in bones, joints, surgical wounds, the bloodstream, heart valves and lungs.

Unlike hospital-associated MRSA, CA-MRSA produces a deadly toxin (Panton-Valentine leukocidin) that destroys white blood cells and living tissue. The toxin can cause severe, often fatal skin infections (necrotizing, or "flesh-eating," fasciitis) and pneumonia.

Photos of two staph infections: one minor, and one red, inflamed, and deep in the skin.

MRSA infections start out as small red bumps that can quickly turn into deep, painful abscesses.

 

Causes

Although the survival tactics of bacteria contribute to antibiotic resistance, humans bear most of the responsibility for the problem. Leading causes of antibiotic resistance include:

Hospitals: Germ incubators
MRSA first emerged in hospitals in the 1960s and since then has been nearly unstoppable. It travels from person to person on clothing, cart handles, bedrails and catheters, and even breeds in the water in floral arrangements, leading hospitals in the United Kingdom to ban flowers in critical care units. Evading every effort to control it, MRSA accounts for half of the major complications in hospitalized people and for tens of thousands of deaths every year.

Scientists think hospital-acquired MRSA is particularly virulent and tenacious because it hides and replicates in a common type of amoeba — a single-celled organism that's present on most surfaces. Amoebas can spread in the air, which means that MRSA may be transmitted without human contact. What's more, germs that breed in amoebas are stronger and more drug-resistant than other pathogens are.

CA-MRSA: Right under your nose
MRSA was confined to healthcare settings until the late 1990s, when four previously healthy children in the Midwest died suddenly of massive MRSA infections. Around the same time, athletes began showing up with hard-to-treat boils, and inmates in some U.S. prisons developed deep abscesses that didn't respond to antibiotic treatment. MRSA also turned up among military recruits and some gay men.

It's likely that what is now called community-associated MRSA (CA-MRSA) entered the wider world in the nostrils of people who picked up the bacteria in hospitals. The Centers for Disease Control and Prevention estimates that at least 1 percent of the population, or 2 million people, now carry CA-MSRA in their noses. Carriers may not be sick, but they can spread the infection and run the risk of becoming ill themselves.

The bacteria spread mainly through skin-to-skin contact and through small cuts and abrasions. Overcrowding and poor hygiene also encourage the spread of staph. Once CA-MRSA enters the body, it causes boils and abscesses and, like hospital strains, sometimes sparks massive infections in the bone, blood or lungs.

Risk factors

Because hospital and community strains of MRSA generally occur in different settings, the risk factors for the two strains differ.

Risk factors for hospital-acquired MRSA include:

These are the main risk factors for CA-MRSA:

Risk factors

Because hospital and community strains of MRSA generally occur in different settings, the risk factors for the two strains differ.

Risk factors for hospital-acquired MRSA include:

These are the main risk factors for CA-MRSA:

When to seek medical advice

Keep an eye on minor skin problems — pimples, insect bites, cuts and scrapes — especially in children. If wounds become infected, see your doctor. Ask to have any skin infection tested for MRSA before starting antibiotic therapy. Drugs that treat ordinary staph aren't effective against MRSA, and their use could lead to serious illness and more resistant bacteria.

Screening and diagnosis

Most often, doctors diagnose MRSA by checking a tissue sample or nasal secretions for signs of drug-resistant bacteria. The sample is sent to a lab where it's placed in a dish of nutrients that encourage bacterial growth (culture). But because it takes about 48 hours for the bacteria to grow, infected people may continue to spread MRSA while awaiting test results, and those who are already ill can become worse or, in the most serious cases, die. Newer tests that can detect staph DNA in a matter of hours are available, but they're more expensive than culture tests, and most hospitals don't yet use them.

Treatment

Although resistant to many common antibiotics, both hospital and community strains of MRSA still respond to certain medications. In hospitals and care facilities, doctors generally rely on the last-ditch antibiotic vancomycin to treat resistant germs. CA-MRSA may be treated with vancomycin or other antibiotics that have proved effective against particular strains. Although vancomycin saves lives, its constant use makes it more likely that germs will soon grow resistant to it as well; some hospitals are already seeing outbreaks of vancomycin-resistant MRSA. To help reduce that threat, doctors often drain abscesses caused by MRSA rather than treat the infection with drugs.

Prevention

Every year, about 2 million Americans develop hospital-acquired infections and 90,000 die of them. Many of these are the result of MRSA, one of the most virulent and tenacious of the antibiotic-resistant germs. Hospitals are fighting back by instituting surveillance systems that track bacterial outbreaks and by investing in products such as antibiotic-coated catheters and gloves that release disinfectants. Still, the best way to prevent the spread of germs is for health care workers to wash their hands frequently, to properly disinfect hospital surfaces and to take other precautions such as wearing a mask when working with people with weakened immune systems.

Here's what you can do to protect yourself, family members or friends from hospital-acquired infections.

Preventing CA-MRSA
Protecting yourself from CA-MRSA — which might be just about anywhere — may seem daunting, but these common-sense precautions can help reduce your risk:

 

Continue with:

H2

H3

H4

H5

H6

H7

H8

H9

H9A

 

 © 2002-2006

Keywords:

Contact Iconocast

Home Page